NEWAMSTERDAM PHARMA CO NV NAMS

US Healthcare Pharmaceutical Preparations
$34.83
-1.0%
52w: $17.96 – $41.45

Latest 13F among current holders filed 10 days ago (Jun 24, 2026)

Price — last 12 months

research preview data
17.9629.7041.45
Jun 20, 2025 Jul 2, 2026
Institutional holders
170
-18 QoQ
13F value
$3.97B
-5.3% QoQ
Smart-money holders
29
signal tier ≥ 2
New smart buyers
2
Q1 2026
Options barometer
0.5×
$9.4M calls / $17.3M puts

Institutional value by quarter

$1.71B
Q1 2024
$1.39B
Q2 2024
$1.28B
Q3 2024
$2.53B
Q4 2024
$2.28B
Q1 2025
$2.11B
Q2 2025
$3.46B
Q3 2025
$4.19B
Q4 2025
$3.97B
Q1 2026

Number of holders

78
Q1 2024
92
Q2 2024
102
Q3 2024
133
Q4 2024
128
Q1 2025
133
Q2 2025
138
Q3 2025
188
Q4 2025
170
Q1 2026

Who owns NAMS?

Q1 2026 filings
FundTypeSharesValue% of fundChange
Frazier Life Sciences Management, L.P. ★3Fundamental concentrated16.9M$542.4M14.0%Held
Capital World Investors Long only active11.1M$355.6M0.0%+11.3%
RA CAPITAL MANAGEMENT, L.P. ★2Fundamental diversified9.6M$305.7M3.2%Held
FCPM III SERVICES B.V. ★3Fundamental concentrated9.2M$294.5M40.8%Held
FMR LLC Long only active8.8M$280.6M0.0%+36.7%
Bain Capital Life Sciences Investors, LLC ★3Fundamental concentrated7.3M$233.9M21.1%Held
WELLINGTON MANAGEMENT GROUP LLP Long only active5.1M$163.8M0.0%+1.6%
DEERFIELD MANAGEMENT COMPANY, L.P. Quant stat arb4.3M$136.5M1.9%+2.4%
VIKING GLOBAL INVESTORS LP ★2Fundamental diversified4.2M$134.6M0.4%Held
Duquesne Family Office LLC ★3Value conviction3.1M$98.3M3.3%Held
Polar Capital Holdings Plc Other2.8M$90.6M0.4%+2.0%
JENNISON ASSOCIATES LLC Other2.8M$88.0M0.1%-21.2%
Medicxi Ventures Management (Jersey) Ltd ★2Fundamental diversified2.7M$85.6M8.7%-6.8%
JANUS HENDERSON GROUP PLC Diversified mechanical2.3M$72.3M0.0%-3.5%
WESTFIELD CAPITAL MANAGEMENT CO LP Other2.2M$70.5M0.3%New
MAVERICK CAPITAL LTD ★2Fundamental diversified2.2M$70.0M0.8%+15.4%
GOLDMAN SACHS GROUP INC Bank broker1.9M$62.3M0.0%+12.8%
Capital International Investors Long only active1.4M$46.1M0.0%-30.1%
ALLIANCEBERNSTEIN L.P. Long only active1.2M$42.1M0.0%-7.8%
ADAGE CAPITAL PARTNERS GP, L.L.C. Other1.1M$35.4M0.1%-21.3%
Castle Hook Partners LP ★2Fundamental concentrated1.0M$33.4M0.7%-3.9%
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Bank broker957.4K$30.6M0.0%+440.9%
Cormorant Asset Management, LP ★3Fundamental concentrated950.0K$30.4M1.5%-5.0%
BlackRock, Inc. Index provider886.6K$28.4M0.0%+4.3%
BANK OF AMERICA CORP /DE/ Bank broker847.1K$27.1M0.0%+84.4%
Aberdeen Group plc Other837.0K$26.8M0.0%+14.7%
JPMORGAN CHASE & CO Bank broker884.2K$25.9M0.0%-11.6%
UBS Group AG Bank broker795.0K$25.4M0.0%-11.6%
FRANKLIN RESOURCES INC Long only active770.2K$24.7M0.0%+0.1%
AMERIPRISE FINANCIAL INC Bank broker753.1K$24.1M0.0%+394.6%
Woodline Partners LP Other752.3K$24.1M0.1%+0.1%
TimesSquare Capital Management, LLC Other752.0K$24.1M0.4%-8.6%
CITADEL ADVISORS LLC Multistrat pod712.1K$22.8M0.0%+12.1%
NWI MANAGEMENT LP Other702.0K$22.5M0.7%Held
Logos Global Management LP ★2Fundamental concentrated600.0K$19.2M1.0%+33.3%
Rock Springs Capital Management LP ★2Fundamental diversified588.8K$18.8M1.1%+5.7%
First Turn Management, LLC ★2Fundamental diversified558.3K$17.9M2.0%-37.5%
MORGAN STANLEY Bank broker555.8K$17.8M0.0%+4.3%
AMERICAN CENTURY COMPANIES INC Diversified mechanical519.5K$16.6M0.0%-13.9%
Artia Global Partners LP ★2Fundamental concentrated503.9K$16.1M3.6%Held
Handelsbanken Fonder AB Diversified mechanical418.9K$13.4M0.0%+0.7%
KENNEDY CAPITAL MANAGEMENT LLC Other408.5K$13.1M0.3%+136.2%
Bank of New York Mellon Corp Diversified mechanical378.8K$12.1M0.0%-3.3%
STEMPOINT CAPITAL LP ★2Fundamental concentrated361.3K$11.6M1.1%+394.2%
Decheng Capital LLC ★3Fundamental concentrated325.1K$10.4M1.6%-45.1%
Slate Path Capital LP ★2Fundamental diversified319.0K$10.2M0.2%Held
MILLENNIUM MANAGEMENT LLC Multistrat pod303.8K$9.7M0.0%+19.3%
Eversept Partners, LP ★2Fundamental diversified285.8K$9.1M0.6%-32.1%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Bank broker285.3K$9.1M0.0%+7.6%
Affinity Asset Advisors, LLC ★2Fundamental diversified275.0K$8.8M0.5%Held

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.